JPRN-UMIN000011030已完成1 期
Phase I clinical trial of WT1 peptide vaccine therapy for pediatric cancers - Phase I clinical trial of WT1 peptide vaccine therapy for pediatric cancers
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 20months-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with severe organ dysfunction, infection under treatment, blood abonormalities or bleeding tendency. 2.Patients with leukemia or lymphoma are excluded.
研究者
相似试验
已完成
1 期
Phase I clinical trial of WT1 peptide-based vaccine for the HLA-A*0201 positive patients with malignant tumors.Malignant solid tumors, Malignant lymphoma, Multiple Myeloma, Acute leukemiaJPRN-UMIN000000933Department of Cancer immunotherapy, Osaka University Medical School10
已完成
1 期
Phase I clinical trial of WT1 peptide-based vaccine combined with Temozoromide for patients with malignant glioma.Malignant GliomaJPRN-UMIN000003504Department of Cancer immunotherapy, Osaka University Graduate School of Medicine3
尚未招募
不适用
Phase I clinical trial of WT1 peptide-based vaccine combined with Temozoromide for pediatric patients with malignant glioma.High grade glioma, Diffuse intrinsic pontine gliomaJPRN-UMIN000013257Osaka University Graduate School of Medicine Pediatrics18
已完成
1 期
Phase I/II clinical trial of WT1 peptide vaccine therapy for lung, breast, pancreas, stomach, and colorectal cancerung, breast, pancreas, stomach, and colorectal cancerJPRN-UMIN000011029Shinshu University50
已完成
不适用
Phase I/II clinical trial of WT1 peptide vaccine for the children with malignanciesJPRN-UMIN000002990Osaka Medical Center and Research Institute for Maternal and Child Health20